The pooled mean difference (MD) using the random-effects model was 0.72 (0.47; 0.98) (p < 0.0001), indicating a significant increase in IL-6 levels in PCOS patients compared to controls. This evidence concerns the gene IL6 and polycystic ovary syndrome.